The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

BACKGROUND: Glioblastoma patients show a great variability in progression free survival (PFS) and overall survival (OS). To gain additional pretherapeutic information, we explored the potential of O-(2-(18)F-fluoroethyl)-L-tyrosine (FET) PET as an independent prognostic biomarker. METHODS: We retros...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Nucl Med Mol Imaging
Autori principali: Poulsen, Sidsel Højklint, Urup, Thomas, Grunnet, Kirsten, Christensen, Ib Jarle, Larsen, Vibeke Andrée, Jensen, Michael Lundemann, af Rosenschöld, Per Munck, Poulsen, Hans Skovgaard, Law, Ian
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5281673/
https://ncbi.nlm.nih.gov/pubmed/27554774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-016-3494-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi